Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    MPACT
Show Display Options
Rank Status Study
1 Recruiting A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup
Conditions: Osteoarthritis;   Arthritis;   Avascular Necrosis;   Fracture of the Femoral Neck or Head;   Congenital Hip Dysplasia
Intervention: Device: Mpact Acetabular Shell
2 Completed Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients
Condition: Kidney Transplantation
Intervention: Drug: GI medication
3 Completed Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests
Condition: Coronary Disease
4 Recruiting NCI-MPACT: Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
Condition: Neoplasms
Interventions: Drug: Temozolomide;   Drug: Everolimus;   Drug: Carboplatin;   Drug: Trametinib DMSO;   Drug: ABT-888;   Drug: MK-1775
5 Recruiting A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.
Condition: Pancreatic Cancer
Intervention: Drug: ABI-007

Indicates status has not been verified in more than two years